These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies. Suárez I; Salmerón-García A; Cabeza J; Capitán-Vallvey LF; Navas N J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():155-164. PubMed ID: 27296731 [TBL] [Abstract][Full Text] [Related]
8. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway. Barnard JG; Singh S; Randolph TW; Carpenter JF J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602 [TBL] [Abstract][Full Text] [Related]
9. The immunogenicity of antibody aggregates in a novel transgenic mouse model. Bessa J; Boeckle S; Beck H; Buckel T; Schlicht S; Ebeling M; Kiialainen A; Koulov A; Boll B; Weiser T; Singer T; Rolink AG; Iglesias A Pharm Res; 2015 Jul; 32(7):2344-59. PubMed ID: 25630815 [TBL] [Abstract][Full Text] [Related]
10. Distribution of Protein Content and Number of Aggregates in Monoclonal Antibody Formulation After Large-Scale Freezing. Hauptmann A; Hoelzl G; Loerting T AAPS PharmSciTech; 2019 Jan; 20(2):72. PubMed ID: 30631964 [TBL] [Abstract][Full Text] [Related]
11. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis. Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480 [TBL] [Abstract][Full Text] [Related]
12. Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study. Martínez-Ortega A; Herrera A; Salmerón-García A; Cabeza J; Cuadros-Rodríguez L; Navas N Int J Biol Macromol; 2018 Sep; 116():993-1003. PubMed ID: 29792967 [TBL] [Abstract][Full Text] [Related]
13. Freezing-induced perturbation of tertiary structure of a monoclonal antibody. Liu L; Braun LJ; Wang W; Randolph TW; Carpenter JF J Pharm Sci; 2014 Jul; 103(7):1979-1986. PubMed ID: 24832730 [TBL] [Abstract][Full Text] [Related]
14. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability. Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456 [TBL] [Abstract][Full Text] [Related]
15. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration. Zidar M; Šušterič A; Ravnik M; Kuzman D Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods. Li W; Yang B; Zhou D; Xu J; Li W; Suen WC J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Physicochemical and Biological Stability of Cetuximab under Various Stress Condition. Farjami A; Siahi-Shadbad M; Akbarzadehlaleh P; Roshanzamir K; Molavi O J Pharm Pharm Sci; 2019; 22(1):171-190. PubMed ID: 31112673 [TBL] [Abstract][Full Text] [Related]
18. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species. Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951 [TBL] [Abstract][Full Text] [Related]
19. Improved Stability of a Model IgG3 by DoE-Based Evaluation of Buffer Formulations. Chavez BK; Agarabi CD; Read EK; Boyne MT; Khan MA; Brorson KA Biomed Res Int; 2016; 2016():2074149. PubMed ID: 27042659 [TBL] [Abstract][Full Text] [Related]
20. The Use of a GroEL-BLI Biosensor to Rapidly Assess Preaggregate Populations for Antibody Solutions Exhibiting Different Stability Profiles. Pace SE; Joshi SB; Esfandiary R; Stadelman R; Bishop SM; Middaugh CR; Fisher MT; Volkin DB J Pharm Sci; 2018 Feb; 107(2):559-570. PubMed ID: 29037466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]